4/A: Strata Critical Medical Form 4 Amendment

Sentiment:

Form 4 Amendment


Melissa M. Tomkiel amends prior Form 4 filing to correct transaction code for shares withheld for tax obligations.

Summary

  • This filing is an amendment to a previously filed Form 4 by Melissa M. Tomkiel, Co-CEO and General Counsel of Strata Critical Medical, Inc.
  • The amendment corrects a transaction code used in the original filing concerning the disposal of Class A common stock on June 8, 2026.
  • The original filing incorrectly used the 'S' code; the amended filing uses the 'F' code to accurately reflect that shares were withheld by the Issuer to satisfy tax withholding obligations related to a restricted stock unit vesting event.
  • The number of securities and ownership details remain accurate as per the original filing.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative correction of a prior filing, with no new material financial or strategic information.

Positives

  • Correction of a filing error to ensure accurate reporting.
  • Confirmation that the transaction was an approved withholding for tax purposes, not a sale.
  • The underlying ownership and transaction details were otherwise correct.

Negatives

  • An initial error in the transaction code required an amendment, indicating a minor administrative oversight.

Future Outlook

No specific future outlook or guidance is provided in this amendment filing.

Management Comments

  • Footnote 1 to the Original Form correctly described the transaction as 'shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.'
  • The reporting person is hereby amending the Original Form to correctly show the 'F' code in Column 3 of Table I.
  • The information set forth in the Original Form was correct in all other respects.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Amendments, like this one, are common to correct administrative errors and ensure transparency regarding beneficial ownership and the nature of transactions, such as stock vesting and associated tax withholdings.

Stakeholder Impact

  • Shareholders: Increased transparency and accuracy in reporting insider transactions.

Key Dates

DateDescription
06/08/2026Date of original transaction (shares withheld).
06/10/2026Date of original Form 4 filing.
06/18/2026Date of amended Form 4 filing.

Keywords

Form 4, SEC Filing, Strata Critical Medical, Melissa M. Tomkiel, Stock Withholding, Tax Obligations, Restricted Stock Units, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.